Thomas Feldthus has joined the Board of Scandion Oncology. Thomas Feldthus represents the main shareholder, Saniona, and he has been involved in Scandion Oncology since it was established in May 2017. Thomas Feldthus (M.Sc., MBA) is vVD, CFO and co-founder of Saniona. Previously, he has been CFO and co-founder of Symphogen A/S.
CEO Nils Brünner says: “We are extremely happy to have Thomas Feldthus in the Board of Scandion Oncology as he has extensive knowledge in biotech start-up, financial strategy and bringing biotech companies to the stock market”